Literature DB >> 3622029

Pulmonary involvement in systemic sclerosis. Association with anti-Scl 70 antibody and digital pitting.

M N Manoussakis, S H Constantopoulos, A E Gharavi, H M Moutsopoulos.   

Abstract

The association of clinical and serologic features of 34 patients with systemic sclerosis was examined. Anti-Scl 70 antibody was found to identify patients with abnormal pulmonary function, particularly impaired diffusion (p less than 0.005), as well as patients with digital pitting scars (p less than 0.025). In addition, the presence of digital pitting scars correlated with impaired diffusion (p less than 0.005), suggesting that interstitial pulmonary disease in systemic sclerosis may, like digital pitting, be secondary to vascular pathology. Anticentromere antibody-positive patients were less likely to have abnormalities of pulmonary function (p less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622029     DOI: 10.1378/chest.92.3.509

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

Review 1.  Interstitial lung disease in systemic sclerosis.

Authors:  O Kaloudi; I Miniati; S Alari; M Matucci-Cerinic
Journal:  Intern Emerg Med       Date:  2007-12-17       Impact factor: 3.397

Review 2.  Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma.

Authors:  Kazuyuki Tsujino; Dean Sheppard
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

3.  Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.

Authors:  P G Vlachoyiannopoulos; U G Dafni; I Pakas; M Spyropoulou-Vlachou; C Stavropoulos-Giokas; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

4.  Early pulmonary disease in systemic sclerosis: a comparison between carbon monoxide transfer factor and static lung compliance.

Authors:  A Scheja; A Akesson; P Wollmer; F A Wollheim
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

5.  Antibodies to topoisomerase II in idiopathic pulmonary fibrosis.

Authors:  R Meliconi; C Negri; R M Borzì; A Facchini; C Sturani; L Fasano; M Fabbri; G C Astaldi Ricotti
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

Review 6.  The clinical relevance of autoantibodies in scleroderma.

Authors:  Khanh T Ho; John D Reveille
Journal:  Arthritis Res Ther       Date:  2003-02-12       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.